产地:San Diego,US储存:液氮
品Pai:ScienCell
运输:干冰
用途:科研
Fibroblasts are mesenchymal cells which are derived from the embryonic mesoderm. They have been used extensively for a wide range of cellular and molecular studies. This is mainly because they are one of easiest types of cells to grow in culture, and their durability makes them amenable to a wide variety of manipulations ranging from studies employing gene transfection to microinjection. There is good evidence that fibroblasts in different parts of the body are intrinsically different [1]. Fibroblasts within tissues are exposed to a dynamic mechnical environment, which influences the structure integrity of both healthy and healing soft tissue. Fibroblasts secrete a nonrigid extracellular matrix that is rich in type I and/or type III collagen [2]. Besides, dermal fibroblasts also secrete large quantities of hyaluronan in response to inflammatory stimuli [3]. During wound healing, dermal fibroblasts switch from a migratory, repopulating phenotype to a contractile, matrix-reassembling phenotype.
HDFn from ScienCell Research Laboratories are isolated from human neonate skin. HDFn are cryopreserved at primary culture and delivered frozen. Each vial contains >5 x 105 cells in 1 ml volume. HDFn are characterized by their spindle morphology and immunofluorescent method with antibody to fibronectin. HDFn are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HDFn are guaranteed to further expand for 15 population doublings at the conditions provided by ScienCell Research Laboratories.
Reference
[1] Conrad, G. W., Hart, G. W., Chen, Y. (1977) Differences in vitro between fibroblast-like cells from cornea, heart, and skin of embryonic chicks. J. Cell Sci. 26:119-137.
[2] Gabbiani, G., Rungger-Brandle, E., The fibroblast. In Tissue Repair and Regeneration (L. E. Glynn, ed.), pp 1-50. Handbook of Inflammation, Vol. 3. Amsterdam, Elsevier, 1981.
[3] Stair S, Carlson KW, Shuster S, Wei ET, Stern R (2004) Mystixin peptides reduce hyaluronan deposition and edema formation. Eur J Pharmacol 2004 Aug 30;450(3):291-6.

